Norman Noble to use Raydiance Corporation's Smart Light ultrafast platform

NewsGuard 100/100 Score

Raydiance Corporation, developer of the world’s first commercial-grade ultrafast laser, announced today that its Smart LightTM ultrafast platform will provide the core technology for an advanced laser machining process, Noble UltraLightTM, to be launched by leading contract manufacturer Norman Noble, Inc. The Noble UltraLightTM process will enable highly precise, athermal machining of bio-absorbable materials, shape memory metals and other exotic materials for the medical device industry.

For over 60 years, Norman Noble has been at the forefront of micro-manufacturing innovation, rapidly adopting new technologies to provide the most advanced precision machining in the industry. In deploying Raydiance Smart LightTM with its Noble UltraLightTM process, Norman Noble will have the most advanced capabilities for creating exacting and reproducible features in vascular stents, drug delivery systems, catheter devices, valves, needles and other medical devices.

“We are pleased to be working with a company that has been a long-time leader in their industry,” said Scott Davison, president of Raydiance. “Highly reliable, commercial-grade ultrafast will have profound effects on a range of advanced manufacturing applications. Norman Noble is ideally positioned to provide these capabilities with its new Noble UltraLightTM.”

Raydiance’s most recent product, Smart Light MDTM , is a software-controlled, ultrafast fiber laser that enables practical, athermal ablation applications for the medical devices industry. Most immediately, Smart Light MDTM is being deployed in integrated workstations to manufacture both metal and bio-absorbable micro stents for cardiovascular applications.

Source:

Raydiance Corporation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
LGM Pharma unveils enhanced analytical testing services and expands CDMO portfolio with additional suppository manufacturing capabilities